NOS2 and cancer: The main concentrations of DETA NONOate used in our studies were lower than 50 μM, which were designed to exogenously provide MDA-MB-231 cells with growth-supporting concentrations of NO mimicking the chronical inflammatory intra-cellular NO produced by iNOS in cancer cells [13].